Nvidia GPUs Slash Cancer Test Turnaround to Under Two Days with 30% Cost Savings
Nvidia’s Parabricks GPUs cut Droplet Biosciences’ genomic analysis timeline from 10 days to under two, slashing alignment from 36 to 3 hours and variant calling from 10 to 1 hour. This partnership doubled detection sensitivity by leveraging lymphatic fluid with 130× more tumor DNA and reduced compute costs by 30%.
1. Collaboration to Speed Residual Cancer Detection
Nvidia has partnered with Droplet Biosciences to apply its Parabricks GPU-accelerated genomics suite to lymphatic fluid tests, enabling cancer residual detection within 24 hours of surgery rather than weeks later with traditional blood-based methods.
2. GPU-Accelerated Workflow Reduces Bottlenecks
By replacing CPU pipelines with Parabricks, Droplet cut sample alignment from 36 hours to 3 and variant calling from over 10 hours to about one, shrinking the overall genomic analysis timeline from around 10 days to under two.
3. Enhanced Sensitivity and Lower Costs
Testing lymphatic fluid yields roughly 130× more tumor-derived DNA than plasma, doubling detection sensitivity for minimal residual disease and, despite higher GPU hourly rates, cutting total computational expenses by an estimated 30%.